JPWO2020067453A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020067453A5 JPWO2020067453A5 JP2020549451A JP2020549451A JPWO2020067453A5 JP WO2020067453 A5 JPWO2020067453 A5 JP WO2020067453A5 JP 2020549451 A JP2020549451 A JP 2020549451A JP 2020549451 A JP2020549451 A JP 2020549451A JP WO2020067453 A5 JPWO2020067453 A5 JP WO2020067453A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- preparation according
- lyophilized preparation
- peptide
- cyclodextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 101800000324 Immunoglobulin A1 protease translocator Proteins 0.000 claims 8
- 229920000858 Cyclodextrin Polymers 0.000 claims 6
- 239000002671 adjuvant Substances 0.000 claims 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 5
- 229960004452 methionine Drugs 0.000 claims 5
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 5
- 229930182817 methionine Natural products 0.000 claims 4
- 150000007524 organic acids Chemical class 0.000 claims 4
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims 4
- 239000004475 Arginine Substances 0.000 claims 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 3
- 239000003002 pH adjusting agent Substances 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims 2
- 239000012931 lyophilized formulation Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 1
- 229930195722 L-methionine Natural products 0.000 claims 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims 1
- 239000008213 purified water Substances 0.000 claims 1
- 239000001384 succinic acid Substances 0.000 claims 1
- 235000002906 tartaric acid Nutrition 0.000 claims 1
- 239000011975 tartaric acid Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018185532 | 2018-09-28 | ||
| JP2018185532 | 2018-09-28 | ||
| PCT/JP2019/038223 WO2020067453A1 (ja) | 2018-09-28 | 2019-09-27 | 注射用組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020067453A1 JPWO2020067453A1 (ja) | 2021-09-09 |
| JPWO2020067453A5 true JPWO2020067453A5 (https=) | 2022-04-08 |
| JP7162675B2 JP7162675B2 (ja) | 2022-10-28 |
Family
ID=69951879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020549451A Active JP7162675B2 (ja) | 2018-09-28 | 2019-09-27 | 注射用組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210338587A1 (https=) |
| EP (1) | EP3858377A4 (https=) |
| JP (1) | JP7162675B2 (https=) |
| KR (1) | KR20210068060A (https=) |
| CN (1) | CN113382746A (https=) |
| AU (1) | AU2019349329A1 (https=) |
| CA (1) | CA3113212A1 (https=) |
| MX (1) | MX2021003660A (https=) |
| NZ (1) | NZ774063A (https=) |
| WO (1) | WO2020067453A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024149926A (ja) * | 2021-08-06 | 2024-10-23 | ブライトパス・バイオ株式会社 | がんペプチドワクチンカクテル製剤、及びその製造方法 |
| WO2024233672A1 (en) * | 2023-05-08 | 2024-11-14 | Integro Theranostics, Llc | Lyophilized products, pharmaceutical compositions, and kits comprising dye-peptide conjugates and derivatives |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1560078B (zh) | 1998-07-31 | 2011-06-22 | 株式会社国际癌症免疫研究所 | 基于癌抑制基因wt1的产物的癌抗原 |
| US20030235557A1 (en) | 1998-09-30 | 2003-12-25 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| US20030072767A1 (en) | 1998-09-30 | 2003-04-17 | Alexander Gaiger | Compositions and methods for WT1 specific immunotherapy |
| ATE399179T1 (de) | 1998-09-30 | 2008-07-15 | Corixa Corp | Zusammensetzungen und verfahren für wt1- spezifische immunotherapie |
| US20050050580A1 (en) | 2000-12-13 | 2005-03-03 | Masashi Gotoh | Transgenic animal expressing hla-a24 and utilization thereof |
| ES2298353T3 (es) | 2001-03-22 | 2008-05-16 | International Institute Of Cancer Immunology, Inc. | Peptido wt1 modificado. |
| US7553494B2 (en) | 2001-08-24 | 2009-06-30 | Corixa Corporation | WT1 fusion proteins |
| WO2003106682A1 (ja) | 2002-06-12 | 2003-12-24 | 中外製薬株式会社 | Hla−a24拘束性癌抗原ペプチド |
| ATE442378T1 (de) | 2002-09-20 | 2009-09-15 | Int Inst Cancer Immunology Inc | Substituierte wt1-peptide |
| US7353321B2 (en) | 2003-01-13 | 2008-04-01 | Sierra Logic | Integrated-circuit implementation of a storage-shelf router and a path controller card for combined use in high-availability mass-storage-device shelves that may be incorporated within disk arrays |
| CN101580538B (zh) | 2003-11-05 | 2013-06-19 | 株式会社国际癌症免疫研究所 | Wt1衍生的hla-dr-结合抗原肽 |
| EP2478913A1 (en) | 2003-12-01 | 2012-07-25 | Sloan-Kettering Institute For Cancer Research | Synthetic HLA binding peptide analogues and uses thereof |
| WO2006078059A1 (ja) | 2005-01-19 | 2006-07-27 | Dainippon Sumitomo Pharma Co., Ltd. | 希釈用乳化組成物および癌ワクチン組成物 |
| ES2542141T3 (es) | 2005-10-17 | 2015-07-31 | Sloan Kettering Institute For Cancer Research | Péptidos WT1 de unión a HLA de clase II, y composiciones y métodos que los comprenden |
| ES2352855T3 (es) | 2005-11-30 | 2011-02-23 | International Institute Of Cancer Immunology, Inc. | Nuevos compuestos peptídicos del tumor de wilms. |
| PL2010209T3 (pl) | 2006-04-10 | 2017-04-28 | Sloan Kettering Inst For Cancer Res | Immunogeniczne peptydy WT-1 i sposoby ich użycia |
| WO2009046738A1 (en) * | 2007-10-09 | 2009-04-16 | Curevac Gmbh | Composition for treating lung cancer, particularly of non-small lung cancers (nsclc) |
| WO2010037395A2 (en) | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| AR076349A1 (es) | 2009-04-23 | 2011-06-01 | Int Inst Cancer Immunology Inc | Peptido auxiliar del antigeno del cancer |
| MY171854A (en) * | 2013-03-29 | 2019-11-05 | Sumitomo Dainippon Pharma Co Ltd | Wt1 antigen peptide conjugate vaccine |
| JP6580581B2 (ja) | 2014-09-27 | 2019-09-25 | 大日本住友製薬株式会社 | 注射用医薬組成物 |
| JP6515182B2 (ja) | 2015-05-20 | 2019-05-15 | 大日本住友製薬株式会社 | Wt1抗原ペプチドおよび免疫調節剤の併用 |
| EP3549957A4 (en) | 2016-11-30 | 2020-08-05 | Sumitomo Dainippon Pharma Co., Ltd. | AUXILIARY PEPTIDE WT1, AND COMBINATION OF DUDIT PEPTIDE AND CONJUGATE PEPTIDE ANTIGENIC FOR CANCER |
-
2019
- 2019-09-27 MX MX2021003660A patent/MX2021003660A/es unknown
- 2019-09-27 AU AU2019349329A patent/AU2019349329A1/en not_active Abandoned
- 2019-09-27 US US17/279,807 patent/US20210338587A1/en active Pending
- 2019-09-27 CN CN201980077600.9A patent/CN113382746A/zh active Pending
- 2019-09-27 KR KR1020217011972A patent/KR20210068060A/ko active Pending
- 2019-09-27 JP JP2020549451A patent/JP7162675B2/ja active Active
- 2019-09-27 CA CA3113212A patent/CA3113212A1/en active Pending
- 2019-09-27 NZ NZ774063A patent/NZ774063A/en unknown
- 2019-09-27 EP EP19864323.1A patent/EP3858377A4/en not_active Withdrawn
- 2019-09-27 WO PCT/JP2019/038223 patent/WO2020067453A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016065060A5 (https=) | ||
| JP2020138981A5 (https=) | ||
| JP2019504086A5 (https=) | ||
| JP2019131596A5 (https=) | ||
| JP2020518599A5 (https=) | ||
| CA3040110A1 (en) | Nsp10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications | |
| JPWO2020067453A5 (https=) | ||
| JP2011513492A5 (https=) | ||
| JP2013525501A5 (https=) | ||
| JP2016505044A5 (https=) | ||
| JP2018528242A5 (https=) | ||
| JP2013531679A5 (https=) | ||
| JP2013513612A5 (https=) | ||
| JP2020015742A5 (https=) | ||
| US20240261398A1 (en) | Adjuvant and vaccine containing adjuvant | |
| JP2012516879A5 (https=) | ||
| EP2593135B1 (fr) | Souches virales modifiées et procédé pour améliorer la production de semences vaccinales de virus influenza | |
| JP2019516730A5 (https=) | ||
| CA3142740A1 (en) | Influenza virus backbone | |
| JP2021502337A5 (https=) | ||
| US12606804B2 (en) | Influenza virus backbone | |
| JP2016517435A5 (ja) | メロペネム誘導体及びその製造法 | |
| JP2014524450A5 (https=) | ||
| JP2022510947A5 (https=) | ||
| JP5189088B2 (ja) | 抗ウイルス剤 |